Trial Profile
Measurement of the Changes in Acceptability of Hepatitis B Immunization Among General Practitioners and Open-care Paediatricians
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Sep 2023
Price :
$35
*
At a glance
- Drugs Hib DTaP hepatitis B poliovirus vaccine (Infanrix hexa) (Primary)
- Indications Hepatitis B
- Focus Pharmacodynamics
- Acronyms PRALINE
- Sponsors GlaxoSmithKline; GSK
- 05 Feb 2013 New trial record